anti-nerve growth factor
Showing 9976 - 10000 of >10,000
Heart Failure, Inflammation, Colchicine Trial in Montréal (Colchicine, Placebo)
Recruiting
- Heart Failure
- +2 more
- Colchicine
- Placebo
-
Montréal, Quebec, CanadaMontreal Heart Institute
Dec 27, 2022
COVID-19 Trial in Lahore (standard of care for COVID-19 as per the hospital guidelines, Quercetin Phytosome (QP))
Completed
- COVID-19
- standard of care for COVID-19 as per the hospital guidelines
- Quercetin Phytosome (QP)
-
Lahore, Punjab, PakistanKing Edward Medical University Teaching Hospital
Jan 23, 2022
Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)
Recruiting
- Kidney Cancer
- +11 more
- 13C-Glucose
- +4 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 1, 2022
Primary Soft-tissue Sarcoma Trial in Lebanon (ABY-029)
Completed
- Primary Soft-tissue Sarcoma
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Aug 25, 2021
Ulcerative Colitis Trial in Edmonton (Synergy-1, Maltodextrin)
Completed
- Ulcerative Colitis
- Synergy-1
- Maltodextrin
-
Edmonton, Alberta, CanadaUniversity of Alberta
Apr 6, 2022
Strategies in Coronary Heart Disease and COVID 19
Not yet recruiting
- Whether the Guidelines on Cardiovascular Disease Prevention Are Being Followed or Not
- Observation
-
Assiut, EgyptAssuit university
Oct 22, 2021
Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, MDS Trial (biological, drug, procedure)
Withdrawn
- Relapsed Acute Myeloid Leukemia
- +2 more
- Cytokine-induced memory-like NK cells
- +4 more
- (no location specified)
Feb 23, 2022
Hypotension on Induction Trial in Toronto (Ringer's Lactate, IV line)
Not yet recruiting
- Hypotension on Induction
- Ringer's Lactate
- IV line
-
Toronto, Ontario, CanadaMount Sinai Hospital
Jun 30, 2022
ISS- Idiopathic Short Stature Trial in Petah tikva (Nutritional supplementation standardized formula, Placebo)
Recruiting
- ISS- Idiopathic Short Stature
- Nutritional supplementation standardized formula
- Placebo
-
Petah tikva, IsraelSchneider children's medical center
Feb 20, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +22 more
- Minoxidil
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jun 8, 2022
Diabetic Neuropathies Trial in Alexandria (botulinum toxin A, Gabapentin, Duloxetine)
Completed
- Diabetic Neuropathies
- botulinum toxin A
- +2 more
-
Alexandria, Egyptfaculty of medicine Alexandria university
Mar 26, 2022
Carotid Artery Stenosis Trial in Camden (Remifentanil, Propofol, and Desflurane, Remifentanil, Dexmedetomidine, and Desflurane,
Completed
- Carotid Artery Stenosis
- Remifentanil, Propofol, and Desflurane
- +2 more
-
Camden, New JerseyCooper University Hospital
Mar 16, 2022
Advanced Solid Tumor Trial in Hangzhou, Shanghai (MSB0254 Injection)
Recruiting
- Advanced Solid Tumor
- MSB0254 Injection
-
Hangzhou, Zhejiang, China
- +1 more
Oct 7, 2021
Old Age; Debility Trial in Porto Alegre (Group-based exercise training during hospitalization)
Not yet recruiting
- Old Age; Debility
- Group-based exercise training during hospitalization
-
Porto Alegre, Rio Grande Do Sul, BrazilHospital de Clínicas de Porto Alegre
Mar 30, 2022
Among Hormone Receptor-positive/Human Epidermal Growth Factor
Recruiting
- Breast Cancer
-
Tokyo, JapanPfizer Japan Inc.
Nov 29, 2021
PCOS Trial in Tehran (Astaxanthin 8 mg, )
Completed
- PCOS
- Astaxanthin 8 mg
- placebo
-
Tehran, Iran, Islamic Republic ofShariati Hospital
Nov 8, 2021
Breast Cancer Trial in Chicago (Core Intervention, E-Coach, Buddy)
Not yet recruiting
- Breast Cancer
- Core Intervention
- +4 more
-
Chicago, IllinoisNorthwestern University
Jul 6, 2023
Multiple Myeloma Trial in Austria, Germany (MOR03087 phase 1 dose escalation, MOR03087, Dexamethasone)
Completed
- Multiple Myeloma
- MOR03087 phase 1 dose escalation
- +4 more
-
Vienna, Austria
- +9 more
Nov 12, 2021
Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma Trial in Seattle (drug,
Recruiting
- Stage II Bladder Cancer AJCC v8
- +2 more
- Cisplatin
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 16, 2022
Epidural Platelet Rich Plasma Injection for Herpes Zoster
Recruiting
- Acute Herpes Zoster Neuropathy
- platelet rich plasma injection
-
Hong Kong, Hong KongThe University of Hong Kong
Sep 8, 2022
Esophageal Cancer Trial in United States (cetuximab, ECF, IC)
Completed
- Esophageal Cancer
- cetuximab
- +3 more
-
Norwalk, Connecticut
- +226 more
Sep 2, 2021
Anesthesia, Local, Needle Phobia Trial in Montréal (Meso-Jet, 2% lidocaine(xylocaine), Needle,2% lidocaine(xylocaine))
Suspended
- Anesthesia, Local
- Needle Phobia
- Meso-Jet, 2% lidocaine(xylocaine)
- Needle,2% lidocaine(xylocaine)
-
Montréal, Quebec, CanadaMcGill University Faculty of Dentistry
Sep 2, 2021
Malnutrition, Malnutrition, Child, Obesity Trial in Addis Ababa (double duty intervention packages)
Not yet recruiting
- Malnutrition
- +4 more
- double duty intervention packages
-
Addis Ababa, Amhara, EthiopiaDebre Berhan University
Mar 28, 2023
Thyroid Cancer Trial in Worldwide (ZD6474 (Vandetanib))
Active, not recruiting
- Thyroid Cancer
- ZD6474 (Vandetanib)
-
Little Rock, Arkansas
- +65 more
Oct 20, 2021